Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 472-477

  Kim, Yang Gyun ^a   Kim, Eun Young ^a   Ihm, Chun Gyoo ^a   Lee, Tae Won ^a   Lee, Sang Ho ^a   Jeong, Kyung Hwan ^a   Moon, Ju Young ^a   Chung, Joo Ho ^b   Kim, Yeong Hoon ^c  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

End stage renal disease; Interleukin 17; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17 RECEPTOR B; INTERLEUKIN 25; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; FEMALE; HUMANS; INTERLEUKIN-17; KIDNEY FAILURE, CHRONIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-17;

EID: 84868606386     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343571     Document Type: Article

References (23)

1. Collins AJ, Kasiske B, Herzog C, et al: Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003; 42(suppl 5):A5-7, S1-230.
2. Cargill M, Altshuler D, Ireland J, et al: Characterization of single nucleotide polymor-phisms in coding regions of human genes. Nat Genet 1999; 22: 231-238.
3. Shlipak MG, Fried LF, Crump C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
4. Keller C, Katz R, Cushman M, et al: Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol 2008; 9: 9.
5. Turner JE, Paust HJ, Steinmetz OM, et al: The Th17 immune response in renal inflammation. Kidney Int 2010; 77: 1070-1075.
6. Zhang Z, Kyttaris VC, Tsokos GC: The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009; 183: 3160-3169.
7. Phoon RK, Kitching AR, Odobasic D, et al: T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2008: 19: 477-485.
8. Crispim JC, Grespan R, Martelli-Palomino G, et al: Interleukin-17 and kidney allograft outcome. Transplant Proc 2009; 41: 1562-1564.
9. Crispin JC, Oukka M, Bayliss G, et al: Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-8766.
10. Gabriel SB, Schaffner SF, Nguyen H, et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
11. Bensen JT, Langefeld CD, Li L, et al: Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1a expression. Kidney Int 2003: 63: 1211-1219.
12. Lee SH, Ihm CG, Sohn SD, et al: Polymorphism in interleukin-1β and interleukin receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol 2004; 24: 410-414.
13. Buraczynska M, Jozwiak L, Ksiazek P, et al: Interleukin-6 gene polymorphism and fast-er progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 2007; 150: 101-105.
14. Bettelli E, Korn T, Kuchroo VK: Th17: the third member of the effector T-cell trilogy. Curr Opin Immunol 2007; 19: 652-657.
15. Wilson NJ, Boniface K, Chan JR, et al: Development, cytokine profile and function of human interleukin-17-producing helper T cells. Nat Immunol 2007; 8: 950-957.
16. Seiderer J, Elben I, Diegelmann J, et al: Role of t he novel Th17 c y tok ine IL-17F in inf lam-matory bowel disease (IBD): upregulated colon ic IL-17 F ex pre ssion i n ac tive Crohn's d is-ease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008; 14: 437-445.
17. Wang YH, Angkasekwinai P, Lu N, et al: IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-1847.
18. Dudas PL, Sague SL, Elloso MM, Farrell FX: Proinflammatory/profibrotic effects of in-terleukin-17A on human proximal tubule epithelium. Nephron Exp Nephrol 2011; 117: 114-123.
19. Crispin JC, Oukka M, Bayliss G, et al: Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-8766.
20. Nogueira E, Hamour S, Sawant D, et al: Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2010; 25: 2209-2217.
21. Gan PY, Steinmetz OM, Tan DS, et al: Th17 cells promote autoimmune anti-myeloper-oxidase glomerulonephritis. J Am Soc Nephrol 2010; 21: 925-931.
22. Kim YG, Ihm CG, Lee TW, et al: Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation. Transplantation 2012; 93: 900-907.
23. Lew BL, Cho HR, Haw S, et al: Association between IL17A/IL17R A gene p oly mor ph i sms and susceptibility to alopecia areata in the Korean population. Ann Dermatol 2012; 24: 61-65.